rotation.to
Following this device: dark.
Free account
rotation.to
Appearance
Following this device: dark.
Drag a card by its title · ⚙ to size, swap or remove

Who

Arthur S. Leibowitz

Director

Company insider

Files Form 4 as: Director, Organogenesis Holdings; Director, Arotech.

In numbers

Trades disclosed
22
Buys
4
Sells
0
Bought
$85K
Sold
$0
Companies
2
Companies where not an officer
2
First trade
1 Apr 2010
Last trade
9 Mar 2026
Last filed
11 Mar 2026

Companies traded

Everywhere else they filed: board seats, 10% stakes, other companies
ORGO Organogenesis HoldingsDirector · Biotechnology · last 9 Mar 20264 buys · 0 sells
ArotechDirector · last 11 Aug 20140 buys · 0 sells

Activity over time

1 Nov 2024 – 1 Oct 2026
01Nov 24May 25Nov 25Apr 26Oct 26

Buys above the line, sells below, each month.

Every trade

TradedCompanyWhatAmount
9 Mar 2026filed 11 Mar 2026ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Bought$13K5,000 at $2.68filing
9 Mar 2026filed 11 Mar 2026ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Bought$13K5,000 at $2.68filing
18 Feb 2026filed 20 Feb 2026ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—48,828 at $0.00filing
18 Feb 2026filed 20 Feb 2026ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—48,828 at $0.00filing
19 Feb 2025filed 21 Feb 2025ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—49,575 at $0.00filing
21 Feb 2024filed 23 Feb 2024ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—51,020 at $0.00filing
22 Feb 2023filed 24 Feb 2023ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—65,737 at $0.00filing
12 Aug 2022filed 15 Aug 2022ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Bought$14K3,000 at $4.76filing
15 Feb 2022filed 17 Feb 2022ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—20,547 at $0.00filing
3 Aug 2021filed 5 Aug 2021ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—5,000 at $0.00filing
16 Feb 2021filed 18 Feb 2021ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—6,318 at $0.00filing
16 Feb 2021filed 18 Feb 2021ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—5,482 at $0.00filing
17 Nov 2020filed 19 Nov 2020ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Bought$23K6,943 at $3.25filing
22 Apr 2020filed 24 Apr 2020ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Code A—18,564 at $0.00filing
3 Sep 2019filed 5 Sep 2019ORGO Organogenesis HoldingsBiotechnologySEC FORM 4 Bought$21K5,000 at $4.20filing
10 Dec 2018filed 12 Dec 2018ORGO Organogenesis Holdingsoption or derivative · BiotechnologySEC FORM 4 Code A—30,000 at $0.00filing
11 Aug 2014filed 13 Aug 2014ArotechSEC FORM 4 Code A—2,793 at $0.00filing
1 Apr 2014filed 3 Apr 2014ArotechSEC FORM 4 Code A—2,412 at $0.00filing
3 Apr 2013filed 4 Apr 2013ArotechSEC FORM 4 Code A—12,931 at $0.00filing
3 Apr 2012filed 4 Apr 2012ArotechSEC FORM 4 Code A—12,097 at $0.00filing

News

No headline names them, or the companies they trade most, lately.

Sectors

Health Care4

Buys in green, sells in red, by the company’s sector.

Related people

Brian GrowChief Commercial Officer · Chief Commercial Officer at Organogenesis Holdings, filing Form 4 there in the last year
Michael Joseph DriscollDirector · Director at Organogenesis Holdings, filing Form 4 there in the last year
Robert CavorsiVice President, Strategy · Vice President, Strategy at Organogenesis Holdings, filing Form 4 there in the last year
Patrick BilboChief Operating Officer · Chief Operating Officer at Organogenesis Holdings, filing Form 4 there in the last year
Antonio S. MontecalvoVice President, Health Policy · Vice President, Health Policy at Organogenesis Holdings, filing Form 4 there in the last year